Pharmaceutical manufacturing
Salveo IV Solutions Plant
A domestic manufacturing plant for intravenous (IV) solutions and basic sterile fluids — among the highest-volume, most import-dependent consumables in any health system. Local production hardens supply-chain resilience against regional shortages and builds pharmaceutical-grade manufacturing capability in Namibia. The portfolio's most advanced healthcare venture, with a dedicated project identity already established.
China relevance
GMP plant design, sterile manufacturing, clean-room technology, IV-fluid production lines.
Development impact
Replaces costly imports; positions Namibia as a SADC exporter of sterile fluids.
Important disclaimer
VOA does not guarantee financing, regulatory approvals or government endorsement. All project information is subject to verification, legal review, technical due diligence and investor assessment. Any regulated financial services, investment advice, securities placement, fund management or capital-raising activities will be undertaken only in accordance with applicable law and, where required, through licensed or appropriately qualified partners.
Key facts
| Sector | Pharmaceutical manufacturing |
|---|---|
| Stage | Project site live |
| VOA role | Strategic shareholder |